![Lloyd James Payne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lloyd James Payne
Direktor/Vorstandsmitglied bei Cyprotex Discovery Ltd.
Aktive Positionen von Lloyd James Payne
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cyprotex Discovery Ltd.
![]() Cyprotex Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex Discovery Ltd. is a British company that specializes in in vitro toxicology studies using a range of techniques such as cell-based assays, mass spectrometer, fluorescence imaging, and qrt-pcr endpoints. The company is based in Abingdon, UK. The company also offers mitochondrial toxicity assays including seahorse assay, glu/gal assay, mitochondrial biogenesis, mitochondrial membrane potential, and mitochondrial mass. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Lloyd James Payne
Ehemalige bekannte Positionen von Lloyd James Payne
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CYPROTEX PLC | Direktor/Vorstandsmitglied | 15.03.2017 | - |
Statistik
International
Vereinigtes Königreich | 3 |
Operativ
Director/Board Member | 2 |
Sektoral
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Cyprotex Discovery Ltd.
![]() Cyprotex Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex Discovery Ltd. is a British company that specializes in in vitro toxicology studies using a range of techniques such as cell-based assays, mass spectrometer, fluorescence imaging, and qrt-pcr endpoints. The company is based in Abingdon, UK. The company also offers mitochondrial toxicity assays including seahorse assay, glu/gal assay, mitochondrial biogenesis, mitochondrial membrane potential, and mitochondrial mass. | Commercial Services |
Cyprotex Ltd.
![]() Cyprotex Ltd. Miscellaneous Commercial ServicesCommercial Services Cyprotex Ltd. provides pharmaceutical research and development services. It offers ADME and pharmacokinetic, Biosciences, in vitro skin and ocular testing, physicochemical profiling, in vitro toxicology, in silico prediction, and endocrine disruption. The company was founded by David Leahy in 1999 and is headquartered in Abingdon, the United Kingdom. | Commercial Services |
- Börse
- Insiders
- Lloyd James Payne
- Erfahrung